AAAAAA

   
Results: 1-13 |
Results: 13
RISK-FACTORS FOR THE DEVELOPMENT OF NEUROLEPTIC-INDUCED AKATHISIA
Authors: MILLER CH HUMMER M OBERBAUER H KURZTHALER I DECOL C FLEISCHHACKER WW
Citation: Ch. Miller et al., RISK-FACTORS FOR THE DEVELOPMENT OF NEUROLEPTIC-INDUCED AKATHISIA, European neuropsychopharmacology, 7(1), 1997, pp. 51-55
UNILATERAL ASSESSMENT OF OLFACTORY DEFICITS IN SCHIZOPHRENIA
Authors: RUPP C ILMBERGER J OBERBAUER H WANKO C SCHOLTZ A HINTERHUBER H
Citation: C. Rupp et al., UNILATERAL ASSESSMENT OF OLFACTORY DEFICITS IN SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 123-123
HEPATOTOXICITY OF CLOZAPINE
Authors: HUMMER M KURZ M KURZTHALER I OBERBAUER H MILLER C FLEISCHHACKER WW
Citation: M. Hummer et al., HEPATOTOXICITY OF CLOZAPINE, Journal of clinical psychopharmacology, 17(4), 1997, pp. 314-317
DOES EOSINOPHILIA PREDICT CLOZAPINE-INDUCED NEUTROPENIA
Authors: HUMMER M SPERNERUNTERWEGER B KEMMLER G FALK M KURZ M OBERBAUER H FLEISCHHACKER WW
Citation: M. Hummer et al., DOES EOSINOPHILIA PREDICT CLOZAPINE-INDUCED NEUTROPENIA, Psychopharmacology, 124(1-2), 1996, pp. 201-204
TERMINATION OF CLOZAPINE TREATMENT
Authors: KURZ M HUMMER M OBERBAUER H KURZTHALER I FLEISCHHACKER WW
Citation: M. Kurz et al., TERMINATION OF CLOZAPINE TREATMENT, Schizophrenia research, 18(2-3), 1996, pp. 4-4
HEPATOTOXICITY OF CLOZAPINE
Authors: HUMMER M OBERBAUER H KURZ M KURZTHALER I SCHNEGG G FLEISCHHACKER WW
Citation: M. Hummer et al., HEPATOTOXICITY OF CLOZAPINE, Schizophrenia research, 18(2-3), 1996, pp. 7-7
COMPARISON OF ACAMPROSATE AND PLACEBO IN LONG-TERM TREATMENT OF ALCOHOL DEPENDENCE
Authors: WHITWORTH AB FISCHER F LESCH OM NIMMERRICHTER A OBERBAUER H PLATZ T POTGIETER A WALTER H FLEISCHHACHER WW
Citation: Ab. Whitworth et al., COMPARISON OF ACAMPROSATE AND PLACEBO IN LONG-TERM TREATMENT OF ALCOHOL DEPENDENCE, Lancet, 347(9013), 1996, pp. 1438-1442
EXTRAPYRAMIDAL SIDE-EFFECTS OF CLOZAPINE AND HALOPERIDOL
Authors: KURZ M HUMMER M OBERBAUER H FLEISCHHACKER WW
Citation: M. Kurz et al., EXTRAPYRAMIDAL SIDE-EFFECTS OF CLOZAPINE AND HALOPERIDOL, Psychopharmacology, 118(1), 1995, pp. 52-56
WEIGHT-GAIN INDUCED BY CLOZAPINE
Authors: HUMMER M KEMMLER G KURZ M KURZTHALER I OBERBAUER H FLEISCHHACKER WW
Citation: M. Hummer et al., WEIGHT-GAIN INDUCED BY CLOZAPINE, European neuropsychopharmacology, 5(4), 1995, pp. 437-440
CLOZAPINE IN THE TREATMENT OF FIRST-EPISODE AND MULTI-EPISODE SCHIZOPHRENIC-PATIENTS
Authors: HUMMER M KURZ M KEMMLER J KURZTHALER I OBERBAUER H FLEISCHHACKER WW
Citation: M. Hummer et al., CLOZAPINE IN THE TREATMENT OF FIRST-EPISODE AND MULTI-EPISODE SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 15(1-2), 1995, pp. 153-153
TARDIVE-DYSKINESIA PREVALENCE RATES DURING A 10-YEAR FOLLOW-UP
Authors: MILLER CH SIMIONI I OBERBAUER H SCHWITZER J BARNAS C KULHANEK F BOISSEL KE MEISE U HINTERHUBER H FLEISCHHACKER WW
Citation: Ch. Miller et al., TARDIVE-DYSKINESIA PREVALENCE RATES DURING A 10-YEAR FOLLOW-UP, The Journal of nervous and mental disease, 183(6), 1995, pp. 404-407
EFFICACY OF MEDIUM-DOSE CLOZAPINE FOR TREATMENT-RESISTANT SCHIZOPHRENIA
Authors: KURZ M HUMMER M KURZTHALER I OBERBAUER H FLEISCHHACKER WW
Citation: M. Kurz et al., EFFICACY OF MEDIUM-DOSE CLOZAPINE FOR TREATMENT-RESISTANT SCHIZOPHRENIA, The American journal of psychiatry, 152(11), 1995, pp. 1690-1691
ASSESSMENT OF THE ALCOHOL-WITHDRAWAL SYNDROME - VALIDITY AND RELIABILITY OF THE TRANSLATED AND MODIFIED CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL SCALE (CIWA-A)
Authors: STUPPAECK CH BARNAS C FALK M GUENTHER V HUMMER M OBERBAUER H PYCHA R WHITWORTH AB FLEISCHHACKER WW
Citation: Ch. Stuppaeck et al., ASSESSMENT OF THE ALCOHOL-WITHDRAWAL SYNDROME - VALIDITY AND RELIABILITY OF THE TRANSLATED AND MODIFIED CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL SCALE (CIWA-A), Addiction, 89(10), 1994, pp. 1287-1292
Risultati: 1-13 |